Kristin Peck

CEO

Zoetis

Kristin Peck was appointed Chief Executive Officer of Zoetis in January 2020. In this role, she leads the world’s leading animal health company, a Fortune 500 organization with approximately $6 billion in annual revenue and 10,000 employees worldwide. Ms. Peck is also a member of the Zoetis Board of Directors.

Prior to becoming CEO, Ms. Peck was executive vice president and group president, U.S. Operations, Business Development and Strategy at Zoetis. Ms. Peck helped usher Zoetis through its Initial Public Offering in 2013 and has been a driving force of change in many roles at the company including Global Manufacturing and Supply, Global Poultry, Global Diagnostics, Corporate Development, and New Product Marketing and Global Market Research.

Before joining Zoetis, Ms. Peck served as executive vice president, Worldwide Business Development and Innovation at Pfizer Inc. and as a member of Pfizer's Executive Leadership Team. In this role, she was responsible for the evaluation of strategic alternatives for Pfizer's Animal Health and Nutrition businesses – paving the way for a public animal health company and attractive investment opportunity.

Prior to joining Pfizer, Ms. Peck held roles at The Boston Consulting Group (BCG) as well as in private equity and real estate finance at The Prudential Realty Group, The O'Connor Group and J.P. Morgan.

Ms. Peck is a member of the Business Roundtable, and also serves on the Advisory Board for the Deming Center for Quality, Productivity and Competitiveness at Columbia Business School. She previously served as a member of the Thomson Reuters’ Board of Directors. As a recipient of the 2019 Feather in Her Cap Award, Ms. Peck has been recognized for her leadership and contributions to the animal health industry, and her work in mentoring women and helping them advance their careers in animal health.
Ms. Peck holds a bachelor's degree from Georgetown University and an MBA from Columbia Business School.